In honor of Epilepsy Week on Neurology Central, we have created an infographic to showcase current treatment options for epilepsy, as well as look ahead at future targets.
Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients
In this research article, the authors determine the the effect of APEH polymorphism on VPA pharmacokinetics in the Chinese population.
We speak to Marc Goodfellow (University of Exeter, UK), who, along with his colleagues, is developing new techniques to identify specific brain regions that trigger seizures in epilepsy.
New research indicates that phagocytosis mediated by microglia is disrupted in neurodegenerative diseases, following observations in brain tissue taken from epilepsy patients.
In celebration of Neuroscience Nurses Week, we talk to Rowena G. Ronquillo, Registered Nurse and Clinical Leader at the Neuroscience Center at Sinai Hospital in Baltimore (MD, USA).
Approval of brivaracetam (BRIVIACT®) as an adjunctive therapy in the treatment of partial-onset seizures in epilepsy patients aged 16 years and older announced by the US-FDA.
Novel model could assist in personalizing surgical procedures for individuals with epilepsy.
David Vodušek presents an overview of a few of the main topics of discussion at the 1st Congress of the European Academy of Neurology.